Administering Antineoplastic Parenteral Cancer Therapy in the Patient's Home: Perspectives of Oncology Nurses-A Descriptive Qualitative Study.

Authors

Tranberg Albin, Kälvemark-Sporrong Sofia, Paulsson Mattias

Published in

Nursing open. Volume 13. Issue 10. Pages e70891.

Abstract

To explore oncology nurses' perspectives on performing cancer treatments with parenteral antineoplastic agents in patients' homes.
A descriptive qualitative study utilizing interviews.
Semi-structured interviews were performed with oncology nurses at a hospital oncology daycare ward between October and November 2022. The interview data were inductively analysed with thematic content analysis.
Five themes were identified: (1) Establishing rapport in the home environment, (2) The complexity of a home, (3) Adverse events-not practicalities, (4) Solitary nursing and (5) Planning enables performance. The nurses believed patients would benefit from home treatment with antineoplastic agents but were concerned about adverse events and working alone. For successful home treatments, nurses believed sufficient resources, education and support were necessary. Practicalities such as transporting, administering and waste handling were not considered complex. Neither did the antineoplastic agents handling seem problematic.
Although positive, especially from the patient perspective, the nurses identified concerns that need to be addressed before implementing oncology hospital-at-home services.
Working in different contexts than the hospital can lead to extended roles and further responsibilities for oncology nurses and possibly facilitate more person-centred care.
This study explored oncology nurses' perspectives on performing parenteral cancer treatments with antineoplastic agents in patients' homes. In general, the nurses were positive, but challenges were identified. The study provides insights into how healthcare developers can incorporate the needs of nurses when designing future hospital-at-home programmes.
COREQ guidelines were used.
No patient or public contribution. WHAT DOES THIS PAPER CONTRIBUTE TO THE WIDER GLOBAL CLINICAL COMMUNITY?: This paper can be used to create tools addressing barriers nurses might have working with hazardous antineoplastic agents in hospital-at-home environments. It emphasizes the importance of education, resources and support to provide nurses with an adequate and safe working environment, improving patient experiences and safety.

PMID:
42834869
Bibliographic data and abstract were imported from PubMed on 06 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.